S0916, MLN1202 in Treating Patients With Bone Metastases
Conditions
- Metastatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: anti-CCR2 monoclonal antibody MLN1202
- GENETIC: polymorphism analysis
- OTHER: laboratory biomarker analysis
Sponsor
SWOG Cancer Research Network
Collaborators